SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is actively trending following its Anktiva treatment receiving accelerated approval for bladder and lung cancer in Saudi Arabia, which the community sees as a pivotal global validation and a significant catalyst. This news, combined with strong preliminary revenue figures and intensifying discussions about a potential short squeeze, is fueling high expectations for the company's role in revolutionizing cancer care and challenging traditional treatments. The company's scientific progress and global reach are key talking points, with many investors anticipating further regulatory and commercial advancements.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is currently experiencing heightened community discussion, driven by ongoing market volatility and perceived institutional "liquidation hunts," with many holders actively accumulating during dips. Talk of a looming "Clarity Act" and broader geopolitical events like tariffs are fueling varied speculation, as long-term investors highlight its core utility while others voice frustration over its subdued price action relative to wider crypto trends.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.Retry

Cardano

Cardano (ADA) is trending amidst sharp price fluctuations and polarized community sentiment, with many anticipating a "massive pump" and a "third wave rally" driven by accumulation. Conversely, a vocal segment of the community views ADA as a "scam" or "dead coin," citing long-term underperformance and questioning its leadership while some look to other assets like AI or XRP.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML is trending strongly following robust earnings from its key customer TSMC, reinforcing optimism around surging AI-driven chip demand. The community is actively discussing ASML's critical "monopoly" in advanced lithography technology, positioning it as an indispensable beneficiary of the ongoing AI infrastructure buildout.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound is at the center of a polarized community discussion, with bulls anticipating a significant "supply shock" and potential price surge as the token nears its maximum circulating supply, buoyed by broader altcoin market tailwinds. However, a strong bearish sentiment highlights ongoing governance concerns, a critical report on the Compound Foundation's performance, and consistent underperformance compared to competitors like AAVE. The debate reflects widespread frustration over the token's struggle to maintain gains and perceived market manipulation.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPDR S&P 500 ETF Trust is a top discussion point as futures show significant movement, driven by heightened geopolitical tensions surrounding potential new tariffs on European countries related to Greenland. The investor community is sharply divided between expectations of a considerable market pullback and those anticipating a swift 'buy the dip' recovery. This macro-level uncertainty is also prompting notable flows into traditional safe-haven assets.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

Anavex Life Sciences is gaining traction from its re-examination request to the European Medicines Agency for blarcamesine and its inclusion in the European Commission's ACCESS-AD initiative, which aims to evaluate the drug for Alzheimer's disease. This is further buoyed by positive discussions with the FDA, where the agency requested the full dataset for its Alzheimer's program and recently issued favorable guidance for adaptive trial designs. The community is actively debating blarcamesine's potential as an oral, ARIA-free treatment for Alzheimer's, anticipating significant regulatory and partnership developments following these validations and the upcoming J.P. Morgan Healthcare Conference.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

ProShares UltraPro QQQ is trending as investors widely anticipate potential Federal Reserve rate cuts, which is fueling optimism for a tech-driven market rebound and year-end rally. The community is actively discussing entry points on recent dips, capitalizing on the instrument's leveraged volatility amid a mixed outlook for AI-related stocks. Many are closely watching for sustained upward momentum as sentiment balances rate cut expectations against broader market valuation concerns.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is a focal point of market discussion, grappling with concerns over its sustained stock underperformance against other leading tech names. The community is actively debating the potential impact of looming geopolitical trade tensions and scrutinizing the strategic implications of Apple's recent AI partnership with Google Gemini. Traders are observing key technical levels and anticipated volatility surrounding its upcoming earnings report, as opinions remain divided on its near-term trajectory amidst strong long-term ecosystem conviction.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore Corp. ($SOC) is trending after a federal appeals court denied an emergency request to block its pipeline restart, signaling a significant step towards resuming operations. This decision is driving strong bullish sentiment and short squeeze speculation, as the community anticipates the company's transition to a major oil producer despite ongoing environmental and state-level legal challenges.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


GQRE
FlexShares Trust - FlexShares Global Quality FlexShares Global Quality

Feed

News

Sentiment

Fundamentals

Info

Latest GQRE News

GQREFlexShares Trust - FlexShares Global Quality FlexShares Global Quality